Introduction

Dr. Emily Atkins discusses the cost-effectiveness of ultra-low-dose quadruple combination therapy for high blood pressure, including the rationale, trial results, and potential global applications.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app